Control Regimen

DRUG5 trials

Sponsors

University of Oxford, Burt's Bees Inc., Colgate Palmolive, Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Conditions

Dental PlaqueDepressive DisorderGingivitisMalariaMatrix MPlaque, DentalRosacea

Phase 1

Adjuvanting Viral Vectored Malaria Vaccines With Matrix M

CompletedNCT01669512

University of OxfordMalaria, Matrix M

Start: 2012-08-31End: 2014-12-31Updated: 2015-01-07

Phase 2

Clinical Investigation to Assess the Efficacy of Manual Toothbrushes in the Reduction of Plaque and Gingivitis.

CompletedNCT06565897

Colgate PalmoliveGingivitis, Plaque, Dental

Start: 2024-07-26End: 2024-09-10Updated: 2026-03-18

Phase 3

Clinical Research Study to Assess the Efficacy of Two Brushing Regimens

CompletedNCT06240481

Colgate PalmoliveDental Plaque, Gingivitis

Start: 2024-09-23End: 2024-12-21Updated: 2026-02-06

Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients

Not yet recruitingNCT07153406

Fundación Pública Andaluza para la gestión de la Investigación en SevillaDepressive Disorder

Start: 2025-09-15End: 2029-01-15Target: 220Updated: 2025-09-04

Unknown Phase

The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea

CompletedNCT03392558

Burt's Bees Inc.Rosacea

Start: 2018-01-01End: 2018-05-01Updated: 2018-06-21

Related Papers

Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™.

2017-09-2130 citations